Three cases of HIV-1 seroreversion
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Three patients were enrolled, two as hemophiliacs, and one with acute EBV infection. Serial serum samples of each patient were tested with at least 3 different HIV antibody EIA tests, an immunofluo-rescent test and two western blots (WB). In the third case, PCR and reverse transcriptase enzyme activity measurement were also done. One of the regularly checked serum samples of hemophiliac patients was reactive with different HIV screening and confirmatory assays. Their next blood samples, two weeks and one month later, respectively, were negative with the same tests. In Case 3. two and a half years after the first examination, the EIA tests results changed to negative, but the WB was still indeterminate. In the case of the two hemophiliac patients, the patients may have been exposed to HIV containing blood products (before 1985), but were not infected. Regular treatment with factor VIII concentrate, in which HIV antigens may be present, can boost the immune response and results in transient seropositivity. In the case of the EBV infected patient, the transient HIV seropositivity may be the consequence of EBV induced proliferation of anti-HIV-antibody producing B cell clones. During our ten year HIV confirmatory practice we tested more than 40000 samples, from which transient seropositivity were observed only in the three cases summarized in this paper.
Lallemant M, Lapointe N, et al: Perinatal HIV Transmission. In AIDS in the World Edited by Mann J., Tarantola D.J.M., Netter T.W Harvard University Press 629–645, 1992.
Roques PA, Gras G, Parnet-Mathieu F;et al: Clearance of HIV infection in 12 perinatally infected children: clinical, virological and immunological data. AIDS 9:F19-F26, 1995.PubMed
Simpson BJ, Andiman WA: Difficulties in assigning HIV-1 infection and seroreversion status in a cohort of HIV-exposed children using serologic criteria established by the Centers for Disease Control and Prevention. Pediatrics 93:840–842, 1994.PubMed
Farzadegan H, Polis MA, Wolinsky SM, et al.: Loss of human immunodeficiency virus Type 1 (HIV-1) antibodies with evidence of viral infection in asymptomatic homosexual men. Ann Intern Med 108:785–790, 1988.PubMed
Burger H, Weiser B, Robinson WS, et al: Transient antibody to lymphadenopathy-associated virus/Human T-Lymphotropic Virus Type III and T-lymphocyte abnormalities in the wife of a man who developed the acquired immunodeficiency syndrome. Ann Intern Med 103:545–547, 1985.PubMed
Roy MJ, Damato JJ, Burke DS: Absence of true seroreversion of HIV-1 antibody in seroreactive individuals. JAMA 270:2178–2179, 1993.CrossRef
Morb Mortal Weekly Report 38, 1989.
Gartner S, Popovic M: Technics in HIV Research. Ed. by Aldovini A, Walker BD, Stockton Press, 1990.
Holmberg S.D., Horsburgh C.R., Byers R.H. Errors in reporting seropositivity for infection with human immunodeficiency virus (HIV). Ann Intern Med 107:679–680, 1988.
Újhelyi E., Králl G., Füst G., et al. Prevalence of HIV-antibod-ies in patients with hemophilia In Hungary. Haematologia. 21:83–89, 1988.PubMed
- Three cases of HIV-1 seroreversion
Pathology & Oncology Research
Volume 3, Issue 3 , pp 224-228
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- transient seropositivity
- Industry Sectors
- Author Affiliations
- 1. National Transfusion Center, POB 44, 1518, Budapest, Hungary
- 2. Blood Transfusion Center, Baja
- 3. National Institute of Hematology and Immunology, Budapest
- 4. National Institute of Public Health, Budapest
- 5. St. Láaszló Hospital, Budapest
- 6. 3rd Department of Medicine, Semmelweis University of Medicine, Budapest, Hungary